Clinical Trial Update: The Cardiovascular Effects of Ginger (Zingiber Officinale) in Patients With Type II Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial updating on cardiovascular effects of ginger (Zingiber officinale) as add-on therapy in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ginger (Zingiber officinale) (Zingiber officinale)

Snippet

Sponsor: Yaounde Central Hospital | Conditions: Cardiovascular Benefits of Zingiber Officinale Roscoe in Patients With Type 2 Diabetes Mellitus Before and After 6 Weeks of add-on Therapy | Phase 4 | Status: COMPLETED